IPOs Numbers Rise In 2024 But Dwindling Returns Could Diminish Potential In 2025

New Year Still Off To Good Start With Five Offerings

 
• By Mandy Jackson
  
Only two drug developers that went public in 2024 are still trading above their IPO values (Shutterstock)

More from Financing

More from Scrip